We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Botox Injection Reduces Post-Surgical Scarring

By HospiMedica staff writers
Posted on 11 Sep 2006
A new study has found that injection of botulinum toxin (botox) within 24 hours of wound closure in the forehead results in less long-term scarring. More...


A study by researchers from the University of Buffalo (NY, USA) examined whether botox-induced immobilization of facial lacerations enhances wound healing and results in less-noticeable scars. The study included 31 patients who suffered wounds to the forehead or had surgery to remove skin cancers from the forehead. The patients received either an injection of botox or saline within 24 hours after wound closure. Photographs were taken at the time the patients received the injections and again six months later, and were reviewed by two facial plastic surgeons who were not involved in the study.

The reviewers used a 10-cm visual analog scale, rating the patients' wound healing on a scale of zero to 10, with 10 representing the best result. The two surgeons' scores were averaged to reach a final score for each patient. The median scores for wounds injected with botox were 8.9, compared to 7.1 for wounds injected with saline. The study was published in the August 2006 issue of Mayo Clinic Proceedings.

"This is the first medication found to minimize scarring,” said senior author Dr. David Sherris, professor and chair of the department of otolaryngology. "The result is of substantial interest in the field of scar treatment. When a wound occurs, especially on the face, people are always worried about the scar. We can now try to improve scars with these injections.”

Botox is the toxic compound produced by the bacterium Clostridium botulinum. It is a protease that breaks down one of the fusion proteins--docking proteins that anchor the vesicle to the membrane--allowing neurons to release acetylcholine at a neuromuscular junction. By inhibiting acetylcholine release, the toxin interferes with nerve impulses and causes paralysis of muscles. A popular use for botox is injection into facial muscles to temporarily relax those muscles to lessen or eliminate wrinkles.



Related Links:
University of Buffalo

New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Fetal Monitor
BT-380
New
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.